Baird John-Paul, Choe Angela, Loveland Jasmine L, Beck Janine, Mahoney Carrie E, Lord Julia S, Grigg Lindsay A
Department of Psychology, Amherst College, Amherst, Massachusetts 01002, USA.
Endocrinology. 2009 Mar;150(3):1202-16. doi: 10.1210/en.2008-0293. Epub 2008 Nov 13.
Orexin-A (ORXA) is an orexigenic neuropeptide produced by the lateral hypothalamus that increases food intake when injected into the brain ventricles or forebrain nuclei. We used a licking microstructure analysis to evaluate hindbrain and forebrain ORXA effects in intact and hindbrain-lesioned rats, to identify the motivational and anatomical bases of ORXA hyperphagia. Intact rats with cannulas in the fourth brain ventricle (4V) received vehicle (artificial cerebrospinal fluid) or ORXA (0.1, 0.4, 1, or 10 nm) injections before 90 min access to 0.1 m sucrose. Meal size and frequency were increased in a double-dissociated manner by the 1 and 10 nm doses, respectively. In experiment 2, 4V 1 nm ORXA was applied to rats offered solutions varied in caloric and gustatory intensity (water and 0.1 and 1 m sucrose). ORXA increased meal frequency for all tastants. ORXA increased meal size only for 0.1 m sucrose, by prolonging the meal without affecting early ingestion rate or lick burst size, suggesting that 4V ORXA influenced inhibitory postingestive feedback rather than taste evaluation. In experiment 3, rats with cannulas in the third ventricle (3V) received dorsal medullary lesions centered on the area postrema (APX group) or sham procedures, and licking for water and 0.1 and 1 m sucrose was evaluated after 1 nm 3V ORXA/artificial cerebrospinal fluid injections. The 3V ORXA increased 0.1 m sucrose meal size and meal frequency for all tastants in the sham group, as observed after 4V ORXA in experiment 2. In the APX group, 3V ORXA injections influenced meal frequency, but they no longer increased meal size. However, the APX rats increased meal size for 0.1 m sucrose after food and water deprivation and after 3V angiotensin II injection. They also showed meal size suppression after 3V injection of the melanocortin-3/4 receptor agonist melanotan II (1 nm). These findings suggest that the area postrema and subjacent nucleus of the solitary tract are necessary for increases in consummatory (meal size) but not appetitive (meal frequency) responses to 3V ORXA. The meal size increases may be due to reduced postingestive feedback inhibition induced by ORXA delivered to either the hindbrain or forebrain ventricles.
食欲素A(ORXA)是一种由下丘脑外侧产生的促食欲神经肽,当注入脑室或前脑核时会增加食物摄入量。我们使用舔舐微观结构分析来评估完整大鼠和后脑损伤大鼠中后脑和前脑的ORXA效应,以确定ORXA导致食欲亢进的动机和解剖学基础。在第四脑室(4V)植入套管的完整大鼠在接触0.1 M蔗糖90分钟前接受载体(人工脑脊液)或ORXA(0.1、0.4、1或10 nM)注射。1 nM和10 nM剂量分别以双解离方式增加了餐量和进食频率。在实验2中,将4V 1 nM的ORXA应用于提供不同热量和味觉强度溶液(水、0.1 M和1 M蔗糖)的大鼠。ORXA增加了所有味觉物质的进食频率。ORXA仅增加了0.1 M蔗糖的餐量,通过延长进餐时间而不影响早期摄食速率或舔舐爆发大小,这表明4V ORXA影响的是抑制性的餐后反馈而不是味觉评估。在实验3中,在第三脑室(3V)植入套管的大鼠接受以最后区(APX组)为中心的延髓背侧损伤或假手术,在注射1 nM 3V ORXA/人工脑脊液后评估对水、0.1 M和1 M蔗糖的舔舐情况。如实验2中4V ORXA注射后所观察到的,3V ORXA增加了假手术组所有味觉物质的0.1 M蔗糖餐量和进食频率。在APX组中,3V ORXA注射影响了进食频率,但不再增加餐量。然而,APX大鼠在禁食禁水后以及3V注射血管紧张素II后增加了0.1 M蔗糖的餐量。它们在3V注射黑皮质素-3/4受体激动剂黑素细胞刺激素II(1 nM)后也表现出餐量抑制。这些发现表明,最后区和毗邻的孤束核对于对3V ORXA的 consummatory(餐量)反应增加是必要的,但对于 appetitive(进食频率)反应则不是。餐量增加可能是由于传递到后脑或前脑室的ORXA诱导的餐后反馈抑制减少所致。